Com tudo isso, será que o Velho Continente está preparado para Donald Trump ou foi pego cochilando na direção (de novo)? Uma tonelada de cocaína, três brasileiros inocentes e a busca por um ...
As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s ...
O economista Álvaro Almeida é o novo director executivo do Serviço Nacional de Saúde (SNS), anunciou o Governo esta terça-feira. Álvaro Santos de Almeida substitui António Gandra d ...
Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...
Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...
Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
Termina a era Vítor Bruno no Dragão, depois da terceira derrota consecutiva, no terreno do Gil Vicente, no domingo à noite, que deixou o FC Porto a quatro pontos da liderança - quando, apenas uma ...
Novo Nordisk has commenced the STEP UP and STEP UP T2D trials to explore the efficacy of semaglutide 7.2mg. Credit: © 2025 Novo Nordisk A/S. Novo Nordisk’s high ...
Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...
and consider upgrading to a web browser that supports HTML5 video A megafraude eleitoral que revoltou boa parte da população também impede o reconhecimento do novo Executivo. Para a RENAMO ...
Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company. But it ...
Lone Star Funds is selecting advisers to explore a possible sale or initial public offering of Portuguese lender Novo Banco SA, according to people familiar with the matter. The private equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback